NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球普拿疼市場:2021∼2028年

Global Paracetamol Market - 2021-2028

出版商 DataM Intelligence 商品編碼 1023080
出版日期 內容資訊 英文 180 Pages
商品交期: 約2個工作天內
價格
全球普拿疼市場:2021∼2028年 Global Paracetamol Market - 2021-2028
出版日期: 2021年08月12日內容資訊: 英文 180 Pages
簡介

又稱乙醯胺酚的普拿疼,是幾百個成藥(OTC)和處方藥的有效成分。還有與其他的有效成分組合,也用於過敏、咳嗽、感冒、流感、失眠症等治療藥。

本報告提供全球普拿疼市場相關調查,市場概要,以及各劑型,各用途,各流通管道,各地區的趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 全球普拿疼市場調查手法和範圍

  • 調查手法
  • 調查的目的和調查範圍

第2章 全球普拿疼市場-市場定義和概要

第3章 全球普拿疼市場-摘要整理

  • 各劑型的市場明細
  • 各用途的市場明細
  • 各流通管道的市場明細
  • 各地區的市場明細

第4章 全球普拿疼市場-市場動態

  • 影響市場的要素
    • 駕駛者
    • 阻礙因素
    • 市場機會
    • 影響分析

第5章 全球普拿疼市場-產業分析

  • 波特的五力分析
  • PEST分析
  • 供應鏈分析
  • 價格分析
  • 法規分析
  • 償付分析
  • 未滿足需求

第6章 全球普拿疼市場-COVID-19分析

  • 市場上的Covid-19分析
    • COVID-19前的市場方案
    • COVID-19目前市場方案
    • COVID-19後或未來方案
  • Covid-19的價格動態
  • 需求與供給的頻譜
  • 大流行時的市場相關的政府舉措
  • 製造商策略性舉措
  • 結論

第7章 全球普拿疼市場-各用途

  • 簡介
    • 市場規模分析,及與前一年同期比較成長分析(%),各用途
    • 市場魅力指數
  • 感冒和咳嗽
    • 簡介
    • 市場規模分析,百萬美元,2018∼2028年,及與前一年同期比較成長分析(%),2020∼2028年
  • 頭痛和發熱
  • 肌肉的痙攣
  • 其他

第8章 全球普拿疼市場-各劑型

  • 簡介
    • 市場規模分析,及與前一年同期比較成長分析(%),各劑型
    • 市場魅力指數
  • 平板電腦
    • 簡介
    • 市場規模分析,百萬美元,2018∼2028年,及與前一年同期比較成長分析(%),2020∼2028年
  • 膠囊
  • 其他

第9章 全球普拿疼市場-各流通管道

  • 簡介
    • 市場規模分析,及與前一年同期比較成長分析(%),各流通管道
    • 市場魅力指數
  • 零售藥局
    • 簡介
    • 市場規模分析,百萬美元,2018∼2028年,及與前一年同期比較成長分析(%),2020∼2028年
  • 醫院藥局
  • 線上藥局

第10章 全球普拿疼市場-各地區

  • 簡介
    • 市場規模分析,百萬美元,2018∼2028年,及與前一年同期比較成長分析(%),2020∼2028年,各地區
    • 市場魅力指數
  • 北美
    • 簡介
    • 主要地區具體動態
    • 市場規模分析,及與前一年同期比較成長分析(%),各劑型
    • 市場規模分析,及與前一年同期比較成長分析(%),各用途
    • 市場規模分析,及與前一年同期比較成長分析(%),各流通管道
    • 市場規模分析,及與前一年同期比較成長分析(%),各國
  • 歐洲
    • 簡介
    • 主要地區具體動態
    • 市場規模分析,及與前一年同期比較成長分析(%),各劑型
    • 市場規模分析,及與前一年同期比較成長分析(%),各用途
    • 市場規模分析,及與前一年同期比較成長分析(%),各流通管道
    • 市場規模分析,及與前一年同期比較成長分析(%),各國
  • 南美
    • 簡介
    • 主要地區具體動態
    • 市場規模分析,及與前一年同期比較成長分析(%),各劑型
    • 市場規模分析,及與前一年同期比較成長分析(%),各用途
    • 市場規模分析,及與前一年同期比較成長分析(%),各流通管道
    • 市場規模分析,及與前一年同期比較成長分析(%),各國
  • 亞太地區
    • 簡介
    • 主要地區具體動態
    • 市場規模分析,及與前一年同期比較成長分析(%),各劑型
    • 市場規模分析,及與前一年同期比較成長分析(%),各用途
    • 市場規模分析,及與前一年同期比較成長分析(%),各流通管道
    • 市場規模分析,及與前一年同期比較成長分析(%),各國
  • 中東和非洲
    • 簡介
    • 主要地區具體動態
    • 市場規模分析,及與前一年同期比較成長分析(%),各劑型
    • 市場規模分析,及與前一年同期比較成長分析(%),各用途
    • 市場規模分析,及與前一年同期比較成長分析(%),各流通管道

第11章 全球普拿疼市場-競爭情形

  • 主要的發展與策略
  • 企業佔有率分析
  • 產品的基準
  • 值得注意的主要企業
  • 有顛覆性技術的企業
  • Start-Ups企業

第12章 全球普拿疼市場-企業簡介

  • GlaxoSmithKline plc
    • 企業概要
    • 產品系列和概要
    • 主要的焦點
    • 財務概要
  • Sanofi
  • Teva Pharmaceuticals USA, Inc
  • Genesis Biotec Inc
  • Mallinckrodt Pharmaceuticals
  • Geno Pharma
  • Biological E
  • CFL Pharma
  • Cipla
  • Dr. Reddy's Labs
  • Novacyl
  • Huzhou Konch
  • Changshu Huagang
  • Zhejiang Kangle
  • Hebei Jiheng

不網羅性的清單

第13章 全球普拿疼市場-DataM

  • 附錄
  • 關於本公司、服務
  • 諮詢方式

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: DMPH3873

Paracetamol Market Overview

The global paracetamol market size was valued US$ XX billion in 2019 and is estimated to reach US$ XX billion by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).

Paracetamol, also named acetaminophen, is an active ingredient in hundreds of over-the-counter (OTC) and prescription medicines. It relieves pain and fever. and, it is also combined with other active ingredients in medicines that treat allergy, cough, colds, flu, and sleeplessness.

Paracetamol Market Dynamics

The paracetamol drugs market growth is driven by the increasing prevalence of conditions like headaches, flu etc. and the increasing demand for pain management drugs.

The growing prevalence and burden of indicative diseases and conditions is expected to drive the growth in the forecast period

Paracetamol is widely used to treat mild to moderate pains, including headaches, menstrual periods, toothaches, backaches, osteoarthritis, or cold/flu aches and pains. Moreover, it is an effective antipyretic used to reduce fever. The rising burden of the indicative conditions and OTC use of the products are driving the market's growth. For instance, according to the Migraine Trust, migraine is the third most common disease in the world (behind dental caries and tension-type headaches). Migraine is more prevalent than diabetes, epilepsy, and asthma combined.

Similarly, according to the World Health Organization (2020), It is estimated that oral diseases affect nearly 3.5 billion people, often leading to pain and discomfort. According to the UN report 2019, there were 703 million persons aged 65 years or over in the world in 2019. The number of older persons is projected to double to 1.5 billion in 2050. Globally, the share of the population aged 65 years or over increased from 6% in 1990 to 9% in 2019. As the older population is more prone to osteoarthritis toothache and other indicative diseases, the market is expected to grow.

However, paracetamol is extensively used by people suffering from high temperatures and aches and pains associated with flu. In tropical areas, influenza occurs throughout the year. In the Northern Hemisphere, the influenza season typically starts in early fall, peaks in mid-February, and ends in the late spring of the following year. The duration and severity of influenza epidemics vary, however, depending on the virus subtype involved. Also, the World Health Organization (2018) estimates that worldwide, annual influenza epidemics result in about 3-5 million cases of severe illness and about 250,000 to 500,000 deaths.

Therefore, owing to the growing prevalence and burden of indicative diseases and conditions, the market for paracetamol is expected to witness the highest growth rate over the forecast period.

Major side effects of drugs is likely to hinder the market growth

The US Food and Drug Administration, in 2013, documented a report that Acetaminophen could lead to rare fatal skin reactions such as Stevens-Johnsons Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). According to research conducted by UK-based scientists, it was found that long-term use of Paracetamol links to High blood pressure and Stroke. Some of the most common side effects of paracetamol overdose are Nausea, Stomach pain, Loss of appetite, weakness, and kidney cancer.

COVID-19 Impact Analysis

The COVID-19 pandemic is expected to have a significant impact on the market. Paracetamol, due to its widespread availability, has been recommended by various healthcare authorities across the world, such as the National Institute for Health and Care Excellence (NICE), the National Health Service (NHS), the CDC, and the Ministry of Health and Family Welfare (MOHFW) of the Government of India, for managing fever in adults and children with COVID-19. COVID-19 pandemic has initially created a high demand for the OTC analgesics, such as paracetamol, which led to restrictions in the export of essential drugs by local authorities while maintaining sufficient stock in their country. However, the majority of paracetamol API is exported from India and China. France's National Pharmaceutical Academy estimates the EU imports 80% of its "active pharmaceutical ingredients," mostly from China and India. The UK medicines regulator estimates that the Chinese manufacturers make around 40% of all APIs used worldwide. Due to the lockdown situation, most markets worldwide faced a shortage of paracetamol, leading to increased prices for paracetamol tablets online and in independent community pharmacies. Amid the COVID-19 situation, the governments of various authorities supported the local manufacturing of paracetamol, strengthening the local market players and competitiveness around the world. For instance, following the COVID-19 crisis, France plans to produce more medicines nationally, starting with paracetamol. In a joint statement, health minister Oliver Veran and junior economy minister Agnes Pannier-Runacher, on 18th June 2020, stated that the government is collaborating with French pharmaceutical companies, Seqens, Upsa, and Sanofi, to ensure the local manufacturing of, and market for, paracetamol. Similarly, such initiatives, collaborations, and strengthening of local manufacturers are expected to bring considerable changes in the paracetamol market worldwide, leading to its growth.

Paracetamol Market Segment Analysis

The tablet segment is expected to hold largest share in this market segment

Paracetamol Tablet has been used as a pain-relieving medication. It is primarily used to treat acute pain. The conditions of acute pain include backache, headache, arthritis and toothache, etc. The active ingredient falls under the class of analgesics, belonging to the category of NSAID. This medication also reduces pain in the body caused due to fever.

The cold and cough segment are expected to hold largest share in this market segment

Many different types of viruses can cause a common cold. The condition is generally harmless, and symptoms usually resolve within two weeks. Consumers depend on OTC cough medicines as a first response to get relief from cough symptoms. Due to the ease of procurement, the sale of paracetamol drugs for cough, cold, and flu has increased, particularly in the high emerging markets, such as India and China. Moreover, the growing population suffering from pain and fever and growing awareness also serve as primary drivers for market growth.

Moreover, according to the Centers for Disease Control and Prevention, worldwide, there are an estimated 24.1 million cases of pertussis and about 160,700 deaths per year. On the other hand, due to the shortage of medicine during the pandemic, many of the regulatory bodies across the world restricted the usage of paracetamol. For example, in the wake of COVID-19, the chemists association in India has decided not to dispense medicines specific to cold, cough, and fever to anyone without a prescription. However, post-pandemic situation, the increased production of paracetamol through the local market players and initiatives to encourage availability is expected to drive the segment growth over the forecast period.

The retail pharmacies segment is expected to hold largest share in this market segment

The retail Pharmacies segment is expected to dominate during the forecast period. Paracetamol drugs are easily, readily available in retail pharmacies as the generic medicine. Retail pharmacies offer convenient services, including home delivery of medicines and availability of all types of drugs and medicines. Moreover, consumer preference for easy availability of products due to busy lifestyles and hectic work schedules is anticipated to boost market growth.

Paracetamol Market Geographical Analysis

North America region holds the largest market share of global paracetamol market

North America region is expected to dominate the overall paracetamol market throughout the forecast period. The market growth is due to the factors such as the existence of key players, high incidence of fever, headaches, migraine in the region, well-structured healthcare system are some of the key factors accountable for its large share in the market. The market growth in the United States is expected to be robust during the forecast period. For instance, according to the Migraine Research Foundation, more than 4 million adults experience chronic daily migraines, with at least 15 migraine days per month, in the United States, and as per the statistics, the growing patient pool and increasing disposable revenue in this country are expected to boost the market's growth of the country.

Moreover, beneficial government initiatives and increased research partnerships are some of the drivers expected to increase the market growth. In this region, the United States has the maximum share due to supportive healthcare policies, higher per tablet cost, the high number of patients, and a developed healthcare market. For instance, in April 2018, Altan Pharma Limited, an Irish specialty pharmaceutical company, announced that the United States Patent and Trademark Office granted two patents to Altan, covering its intravenous formulation of acetaminophen (paracetamol).

Paracetamol Market Competitive Landscape

The global paracetamol market is moderately competitive with presence of global companies. Some of the key players which are contributing to the growth of the market include GlaxoSmithKline plc, Teva Pharmaceuticals USA, Inc., Genesis Biotec Inc., Mallinckrodt Pharmaceuticals, Geno Pharma, Biological E, CFL Pharma, Cipla, Dr. Reddy's Labs, Sanofi, Novacyl, Huzhou Konch, Changshu Huagang, Zhejiang Kangle and Hebei Jiheng. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market globally. For instance, In March 2020, Johnson & Johnson announced that it will be ramping up production of its flagship product Tylenol which is an over-the-counter pain killer.

Paracetamol Market Key Companies to Watch

GlaxoSmithKline plc

Overview: GlaxoSmithKline plc is a British multinational pharmaceutical company headquartered in Brentford, UK. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham. The business segments include Pharmaceuticals, Vaccines and Consumer healthcare. GSK is extending 50 years of leadership in respiratory medicine with continued innovation in the development of treatments for asthma, chronic obstructive pulmonary disease (COPD), and other debilitating respiratory conditions. It operates its business in over 115 countries worldwide.

Product Portfolio: The Pharmaceuticals business has a broad portfolio of innovative and established medicines in respiratory, HIV, immuno-inflammation and oncology.

Key developments: In February 2020, GlaxoSmithKline got approval from the Food and Drug Administration for Advil Dual Action, with Acetaminophen as an over-the-counter (OTC) product for pain relief.

Why Purchase the Report?

  • Visualize the composition of the paracetamol market segmentation by application, by dosage form and by distribution channel highlighting the key commercial assets and players.
  • Identify commercial opportunities in paracetamol market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of paracetamol market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global paracetamol market report would provide an access to an approx. 61 market data table, 55 figures and 200 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Market Segmentation:

Global Paracetamol Market- By Dosage Form

  • Tablet
  • Capsules
  • Others

Global Paracetamol Market- By Application

  • Headache and Fever
  • Cold and Cough
  • Muscle Cramps
  • Others

Global Paracetamol Market- By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Paracetamol Market - By Region

  • North America
  • Europe
  • Asia-Pacific
  • Middle East & Africa
  • South America

Table of Contents

1. Global Paracetamol Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Paracetamol Market - Market Definition and Overview

3. Global Paracetamol Market - Executive Summary

  • 3.1. Market Snippet by Dosage form
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by Distribution channel
  • 3.4. Market Snippet by Region

4. Global Paracetamol Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Driver
      • 4.1.1.1. The growing prevalence and burden of indicative diseases and conditions
    • 4.1.2. Restraints:
      • 4.1.2.1. Major side effects of drugs
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Paracetamol Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. PEST Analysis
  • 5.3. Supply Chain Analysis
  • 5.4. Pricing Analysis
  • 5.5. Regulatory Analysis
  • 5.6. Reimbursement Analysis
  • 5.7. Unmet Needs

6. Global Paracetamol Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Paracetamol Market - By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
    • 7.1.2. Market Attractiveness Index, By Application Segment
  • 7.2. Cold and Cough
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 7.3 Headache and Fever
  • 7.4 Muscle Cramps
  • 7.5 Others

8. Global Paracetamol Market - By Dosage form

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Dosage form
    • 8.1.2. Market Attractiveness Index, By Dosage form
  • 8.2. Tablet*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 8.3. Capsules
  • 8.4. Others

9. Global Paracetamol Market - By Distribution Channel

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution channel
    • 9.1.2. Market Attractiveness Index, By Distribution channel
  • 9.2. Retail Pharmacies*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 9.3. Hospital Pharmacies
  • 9.4. Online Pharmacies

10. Global Paracetamol Market - By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Dosage form
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Dosage form
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Dosage form
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Dosage form
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Dosage form
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel

11. Global Paracetamol Market - Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking
  • 11.4. Key Companies to Watch
  • 11.5. Company with disruptive technology
  • 11.6. Start Up Companies

12. Global Paracetamol Market - Company Profiles

  • 12.1. GlaxoSmithKline plc*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Sanofi
  • 12.3. Teva Pharmaceuticals USA, Inc
  • 12.4. Genesis Biotec Inc
  • 12.5. Mallinckrodt Pharmaceuticals
  • 12.6. Geno Pharma
  • 12.7. Biological E
  • 12.8. CFL Pharma
  • 12.9. Cipla
  • 12.10. Dr. Reddy's Labs
  • 12.11. Novacyl
  • 12.12. Huzhou Konch
  • 12.13. Changshu Huagang
  • 12.14. Zhejiang Kangle
  • 12.15. Hebei Jiheng

LIST NOT EXHAUSTIVE

13. Global Paracetamol Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us